An improved,cost-effective,and convenient process,using cin-namoyl as hydroxyl protective group and tosyl as the leaving group for gemcitabine(1)is described.The overall yield obtained from this newly developed process is around 10%,including two stereospecific crystallizations,and the quality of the product complies with the requirements of USP30.
展开▼
